Oaktree Acquisition Corp III Life Sciences
OACCBuild a strategy around OACC
Oaktree Acquisition Corp III Life Sciences AI Insights
Informational only. Not investment advice.Snapshot
- SPAC with zero revenue - entire 2.0M net income TTM from 2.2M interest on trust assets. Operating loss of 226K from G&A.[Interest Income]
- Trading at 1.35x P/B with 7.85 book value per share. 193M equity vs 260M market cap implies 35% premium to NAV.[Price to Book Ratio]
- Near-zero debt (12K) with 1.3M cash outside trust. Burn rate of 226K/yr G&A gives ~6 years runway before trust access needed.[Cash and Cash Equivalents]
Watch Triggers
- Price to Book Ratio: Falls below 1.05x — Signals market losing confidence in deal; approaching redemption floor creates entry point
- Cash and Cash Equivalents: Drops below 500K — Would indicate accelerating burn or extension costs; trust access timeline pressure
- Volume: Spikes above 100K daily — Unusual activity often precedes deal announcement or material news
Bull Case
Oaktree sponsor pedigree and 193M trust capital positioned for life sciences deal. Premium to NAV (1.35x P/B) reflects deal optionality value.
Minimal cash burn (226K G&A TTM) preserves trust value. Interest income (2.2M) exceeds operating costs by 10x, growing NAV.
Bear Case
35% premium to NAV creates immediate downside if no deal materializes. Redemption at ~7.85/share vs 10.58 market price = 26% loss risk.
Ultra-low volume (2,926 shares TTM) creates liquidity trap. Position sizing severely constrained; exit may require significant discount.
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage OACC's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
SPAC value hinges entirely on deal announcement - current premium suggests market expects target within 12m
- Life sciences focus limits target universe
- Oaktree sponsor reputation for deal sourcing
- 35% NAV premium prices in deal optionality
Valuation Context
Caveats
OACC Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
Beta 5Y (Monthly) | unknown | — |
OACC Dividend History
OACC Stock Splits
OACC SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
05/13/26 | 03/31/26 | 10-Q | |
03/26/26 | 12/31/25 | 10-K | |
11/13/25 | 09/30/25 | 10-Q | |
08/12/25 | 06/30/25 | 10-Q | |
05/14/25 | 03/31/25 | 10-Q | |
12/31/24 | 12/31/24 | 10-K | |
10/24/24 | 09/30/24 | 424B4 |